Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

249 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
BCL3 rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases.
Carbo-Meix A, Guijarro F, Wang L, Grau M, Royo R, Frigola G, Playa-Albinyana H, Buhler MM, Clot G, Duran-Ferrer M, Lu J, Granada I, Baptista MJ, Navarro JT, Espinet B, Puiggros A, Tapia G, Bandiera L, De Canal G, Bonoldi E, Climent F, Ribera-Cortada I, Fernandez-Caballero M, De la Banda E, Do Nascimento J, Pineda A, Vela D, Rozman M, Aymerich M, Syrykh C, Brousset P, Perera M, Yanez L, Ortin JX, Tuset E, Zenz T, Cook JR, Swerdlow SH, Martin-Subero JI, Colomer D, Matutes E, Bea S, Costa D, Nadeu F, Campo E. Carbo-Meix A, et al. Among authors: rozman m. Haematologica. 2024 Feb 1;109(2):493-508. doi: 10.3324/haematol.2023.283209. Haematologica. 2024. PMID: 37560801 Free PMC article.
Clinical Characteristics and Outcomes of Patients with Primary and Secondary Myelofibrosis According to the Genomic Classification Using Targeted Next-Generation Sequencing.
Garrote M, López-Guerra M, Arellano-Rodrigo E, Rozman M, Carbonell S, Guijarro F, Santaliestra M, Triguero A, Colomer D, Cervantes F, Álvarez-Larrán A. Garrote M, et al. Among authors: rozman m. Cancers (Basel). 2023 Jul 31;15(15):3904. doi: 10.3390/cancers15153904. Cancers (Basel). 2023. PMID: 37568719 Free PMC article.
Characteristics and long-term outcome in a large series of chronic myelomonocytic leukaemia patients including 104 formerly referred to as oligomonocytic.
Castaño-Díez S, Pomares H, Esteban D, Guijarro F, Jiménez-Vicente C, Zugasti I, Álamo JR, Mayayo VT, López-Guerra M, de la Fuente C, Charry P, Cortés-Bullich A, Bataller Á, Maluquer C, Colomer D, Rozman M, Arnan M, Xicoy B, Esteve J, Díaz-Beyá M. Castaño-Díez S, et al. Among authors: rozman m. Br J Haematol. 2024 Mar;204(3):892-897. doi: 10.1111/bjh.19217. Epub 2023 Nov 27. Br J Haematol. 2024. PMID: 38013238
Infrequent Presentations of Chronic NPM1-Mutated Myeloid Neoplasms: Clinicopathological Features of Eight Cases from a Single Institution and Review of the Literature.
Castaño-Díez S, Guijarro F, López-Guerra M, Pérez-Valencia AI, Gómez-Núñez M, Colomer D, Díaz-Beyá M, Esteve J, Rozman M. Castaño-Díez S, et al. Among authors: rozman m. Cancers (Basel). 2024 Feb 7;16(4):705. doi: 10.3390/cancers16040705. Cancers (Basel). 2024. PMID: 38398096 Free PMC article. Review.
Whole Exome Sequencing of Intermediate-Risk Acute Myeloid Leukemia without Recurrent Genetic Abnormalities Offers Deeper Insights into New Diagnostic Classifications.
Guijarro F, Castaño-Díez S, Jiménez-Vicente C, Garrote M, Álamo JR, Gómez-Hernando M, López-Oreja I, Morata J, López-Guerra M, López C, Beà S, Costa D, Colomer D, Díaz-Beyá M, Rozman M, Esteve J. Guijarro F, et al. Among authors: rozman m. Int J Mol Sci. 2024 Aug 8;25(16):8669. doi: 10.3390/ijms25168669. Int J Mol Sci. 2024. PMID: 39201354 Free PMC article.
Chronic myelomonocytic leukemia with NPM1 mutation or acute myeloid leukemia?
Castaño-Díez S, Álamo JR, López-Guerra M, Gómez-Hernando M, Zugasti I, Jiménez-Vicente C, Guijarro F, López-Oreja I, Esteban D, Charry P, Torrecillas V, Mont-de Torres L, Cortés-Bullich A, Bataller Á, Guardia A, Munárriz D, Carcelero E, Riu G, Triguero A, Tovar N, Vela D, Beà S, Costa D, Colomer D, Rozman M, Esteve J, Díaz-Beyá M. Castaño-Díez S, et al. Among authors: rozman m. Oncologist. 2024 Sep 30:oyae246. doi: 10.1093/oncolo/oyae246. Online ahead of print. Oncologist. 2024. PMID: 39349391 Free article.
Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypes.
Charalampopoulou S, Chapiro E, Nadeu F, Zenz T, Beà S, Martínez-Farran A, Aymerich M, Rozman M, Roos-Weil D, Bernard O, Susin SA, Parker H, Walewska R, Oakes CC, Strefford JC, Campo E, Matutes E, Duran-Ferrer M, Nguyen-Khac F, Martín-Subero JI. Charalampopoulou S, et al. Among authors: rozman m. Blood Adv. 2024 Dec 24;8(24):6297-6307. doi: 10.1182/bloodadvances.2024013327. Blood Adv. 2024. PMID: 39471431 Free PMC article.
Blastic Plasmacytoid Dendritic Cell Neoplasm: A Single-Center Experience. Clinical Characterization, Mutational Landscape, and Clinical Outcome of Patients Undergoing Hematopoietic Stem Cell Transplantation Intensive Therapy.
Gil-Lianes J, Mozas P, Baumann T, Combalia A, Baliu-Piqué C, García A, Rovira M, López-Guerra M, Villamor N, Colomer D, Rozman M, Esteve J, Estrach T. Gil-Lianes J, et al. Among authors: rozman m. Actas Dermosifiliogr. 2024 Jun 7:S0001-7310(24)00487-3. doi: 10.1016/j.ad.2023.09.029. Online ahead of print. Actas Dermosifiliogr. 2024. PMID: 38852841 English, Spanish.
Blastic Plasmacytoid Dendritic Cell Neoplasm: A Single-Center Experience. Clinical Characterization, Mutational Landscape, and Clinical Outcome of Patients Undergoing Hematopoietic Stem Cell Transplantation Intensive Therapy.
Gil-Lianes J, Mozas P, Baumann T, Combalia A, Baliu-Piqué C, García A, Rovira M, López-Guerra M, Villamor N, Colomer D, Rozman M, Esteve J, Estrach T. Gil-Lianes J, et al. Among authors: rozman m. Actas Dermosifiliogr. 2024 Nov 2:S0001-7310(24)00871-8. doi: 10.1016/j.ad.2024.11.002. Online ahead of print. Actas Dermosifiliogr. 2024. PMID: 39491613 English, Spanish.
AML typical mutations (CEBPA, FLT3, NPM1) identify a high-risk chronic myelomonocytic leukemia independent of CPSS molecular.
Castaño-Díez S, López-Guerra M, Zugasti I, Calvo X, Schulz FI, Avendaño A, Mora E, Falantes J, Azaceta G, Ibáñez M, Chen T, Notario C, Amer N, Palomo L, Pomares H, Vila J, Bernal Del Castillo T, Jiménez-Vicente C, Esteban D, Guijarro F, Álamo J, Cortés-Bullich A, Torrecillas-Mayayo V, Triguero A, Mont-de Torres L, Carcelero E, Cardús A, Germing U, Betz B, Rozman M, Arenillas L, Zamora L, Díez-Campelo M, Xicoy B, Esteve J, Díaz-Beyá M. Castaño-Díez S, et al. Among authors: rozman m. Blood Adv. 2025 Jan 14;9(1):39-53. doi: 10.1182/bloodadvances.2024013648. Blood Adv. 2025. PMID: 39388660
249 results